chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The pt developed fever of 100 deg F on 04/28/2002 and loss of appetite, runny nose and cranky. The pt also developed diffuse blotchy rash on 05/04/2002. The pt was diagnosed with measles. On 05/14/2002, the child recovered.
Red raised knot at injection site  Armpit is very sore to touch and feels swollen
Staff reported that she experienced rash at injection site followed by "hives all over" (scalp, arms, legs, back of neck, chest, back of legs) itchiness, shortness of breath for 2 days with persistent cough, severe body aches, fever, chills, sweats, fatigue, headache, loss of appetite
Pt started with symptoms of excessive tearing in his left eye about 48 hours after receiving his vaccine. This then progressed into obvious facial drooping, and impairment of facial nerve, inability to blink L eye or raise L eyebrow.
A nurse reported that a 49 year old female NP received Flu Shield (2000-2001) vaccine on 11/3/00. The NP stated that the shot "felt like a normal shot"; however, within a few days, she developed muscle tenderness at the injection site. The soreness in this area continued and she received physical therapy to the area in 12/00. She was treated with rofecoxib (Vioxx) for the discomfort. On 1/4/01, an MRI was done which revealed "muscle tears and irritation to posterior aspect of left rotator cuff-tendonosis". The nurse practitioner stated that this was the same area from where she had been experiencing discomfort since the immunization. She denied other injury to the area. This report was considered serious since muscle injury and injection site pain were considered "Medically Important" in this case. No additional information was available as of the date of this report. no additional info was added with this follow up. On 02/21/02, follow up was recieved from the reporter. The pt was continued to experience pain. On 09/06/01, arthroscopy of the shoulder was performed; the surgeon shaved bone and repaired the rotator cuff. She was hospitalized for 23 hrs. The pt gradually developed increased range of motion and slowly recovered. She is currently doing well.
Itchiness around the injection site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness around the injection site) and FATIGUE (Fatigue) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Dry skin (Dry skin which is naturally itchy) and Itchy skin (Dry skin which is naturally itchy).    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness around the injection site) and FATIGUE (Fatigue). At the time of the report, VACCINATION SITE PRURITUS (Itchiness around the injection site) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that the patient received the vaccine in his right arm shoulder deltoid muscle.  Concomitant medication list was not provided. Treatment information was not provided.   This case was linked to MOD-2022-461699 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jan-2022: Updated reporter contact details.
BODY ACHES; FLU LIKE SYMPTOMS; SLIGHT DIARRHEA BUT NOT BAD; FEELS LIKE SINUS INFECTION; FEELING BLAH; SORE ARM/MUSCLES; CHILLS THAT COME AND GO; This spontaneous report received from a patient concerned a 68 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included sarcoidosis autoimmune disease, arthritis, and arthritis pain. The patient experienced swelling around ankles when treated with felodipine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included paracetamol for arthritis pain. On 09-APR-2021, the subject experienced body aches. On 09-APR-2021, the subject experienced flu like symptoms. On 09-APR-2021, the subject experienced slight diarrhea but not bad. On 09-APR-2021, the subject experienced feels like sinus infection. On 09-APR-2021, the subject experienced feeling blah. On 09-APR-2021, the subject experienced sore arm/muscles. On 09-APR-2021, the subject experienced chills that come and go. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body aches, flu like symptoms, chills that come and go, slight diarrhea but not bad, and sore arm/muscles, and the outcome of feels like sinus infection and feeling blah was not reported. This report was non-serious.
a skin rupture on her lips; body aches; joint pain; a rash on her body/Rash; fever; a very bad headache; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), CHAPPED LIPS (a skin rupture on her lips), PAIN (body aches), RASH (a rash on her body/Rash) and ARTHRALGIA (joint pain) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 006N20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and TIMOLOL for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TENDERNESS (tenderness). On 11-Mar-2021, the patient experienced PYREXIA (fever). 11-Mar-2021, the patient experienced HEADACHE (a very bad headache). On 17-Mar-2021, the patient experienced RASH (a rash on her body/Rash). On 18-Mar-2021, the patient experienced CHAPPED LIPS (a skin rupture on her lips) and PAIN (body aches). 18-Mar-2021, the patient experienced ARTHRALGIA (joint pain). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, TENDERNESS (tenderness), CHAPPED LIPS (a skin rupture on her lips), PAIN (body aches), RASH (a rash on her body/Rash), ARTHRALGIA (joint pain), PYREXIA (fever) and HEADACHE (a very bad headache) outcome was unknown.            Concomitant medications included unspecified supplements.   This case was linked to MOD-2021-059388 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Onset date of the event rash was updated.
Pt has no temp, area not reddened, not irritated, not warm to the touch. There is a small area where the needle was inserted that has a gray to silver particle that is raised, but it seems to be interdermal. Mom noticed this right after the blood & scab went away- about 1 week- Inj site is Lt lateral thigh.
Pt recvd vax & exp rt thoracic back pain; 12SEP92 had 3 lesions on rt abdo & the thoracic back pain cont to inc in intensity; also pain; 22SEP92 itching & blisters & herpes zoster;
Circular but splotchy rash a site of injection. Appeared 10 days after receiving the vaccine.
I accidentally injected just the diluent the first time. I immediately realized and revaccinated patient with correct dose in the other arm. Patient reports no abnormal adverse events.
Note that after shot number 1 , I had nothing more than a sore arm, but I did get the raised welt 'Covid Arm' about a week after. No pain after day 1.  After shot #2 on May 1, the arm has been minimally sore. I felt totally normal for about 24 hours. After about 24 hours, however, I started to feel fatigued and brain-fogged. Then I developed muscle aches in the neck and shoulder area. Also got a low-grade fever (normal for me is 97.5 and when I checked it was 98.1). Taste was off during that time as well. I felt hungry but my stomach was queasy and nothing tasted right, so I didn't eat much. After 24 hours of that, where I slept a lot, I improved quickly.  Could almost feel stronger by the hour. Monday (day 2) I worked all day (on the computer) and struggled a little, but was mostly fine. After work, I did some work landscaping with digging and hard work and was fine. Then a day later I noticed the injection site in the left arm had a raised welt, but smaller and not discolored in the same way it was after the first shot. (After the first shot, the welt that showed up a week later was not colored in the middle but had a reddish but subtle ring around the injection site, I'd say about 3 inches in diameter.) I noticed small, red patches in a line surrounding the welt. Nothing painful, just interesting. Now, it looks more uniformly red and it is tiny bit tender, but nothing bad. Energy is back to 100%. Brain is working perfectly. I wanted to report my symptoms to help others and to fill in data.
51 yo woman with no known history of cardiac disease who experienced onset of persistent nausea 5 days post vaccination.  8 days post vaccination developed diarrhea.  13 days post vaccination experienced the onset of chest pain and shortness of breath in addition to persistent nausea.  Some diaphoresis that night.  The following day (2 weeks post vax) she contacted employee health to report her symptoms.  She was referred to the ER where work-up included EKG (with chest pain present), cardiac enzymes, chest Xray, Doppler ultrasound of legs to r/o DVT - all of which were normal.  Her chest pain persisted so she was admitted to the cardiac care unit for overnight observation.  Repeat cardiac enzymes x 2 were normal and and echo done the following day was normal.  The patient was found to have low potassium (felt to be due to persistent diarrhea) and received potassium supplements.  After thorough evaluation and observation, her chest pain was felt to not be cardiac in origin and she was discharged on 3/28.
Information has been received from a medical assistant referring to an 18 years old patient of unknown gender. Information about concomitant medications, medical history and drug reactions was not provided. On an unknown date, the patient was administered with an adult dose of RECOMBIVAX HB (route, lot number and expiration date were not reported) for prophylaxis (incorrect dose administered). No adverse effects were reported.
Child developed itching and rash of legs and genital area after DTaP #4 administration left leg. Followed up 9/18/03 Benadryl (1 tsp every 4 to 6 hours). X-ray followed up 9/19/03. Continued Benadryl, cream, Prednisolone 5mg BID for 4 days. Return 1 week.
Case number PHEH2013US020246 is an initial spontaneous report received from a consumer on 26 Sep 2013. This report refers to a male patient whose age was not reported. His medical history and concomitant medications were not reported. He was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown date. It was reported that on an unknown date after vaccination, he had mild symptoms of flu. The outcome of the event was not reported. No further information was provided.
Debilitating tinnitus. Pressure in ears, intermittent pulsing sensation. Headaches, and dizziness.   I?ve gotten my ears irrigated to clean them out. Tinnitus persists, pressure and pain remains.
10 minutes after receiving vaccine patient complained of head heaviness, palpitations and feeling hot in the ears.  BP = 166/97, HR = 129, O2 SAT = 100%, Temp. = 98
cried continusouly until seen in ER 5 hrs later-dx w/OM in ER t101.2 no OM per MD in PM a/vax given t100.2;
Initial nausea, aches and chills and very sore arm.  Two days following shot allergic reaction in the form of hives and itching on lower extremities and slightly on lower side of upper arms.  (No adverse reaction to first shot)
This spontaneous report as received from an registered nurse refers to a staff member of unknown age. The staff member administered a dose of MMR II (lot # H015829, Expired date: 24-AUG-2014, dose and route not reported) in the physician's office on 17-JAN-2013. The staff member experienced burning in her eye after an unspecified amount of MMR II splashed up into her eye from the syringe due to the movement of the patient's arm during administration of the vaccine of MMR II. The patient flushed eye with water. The staff member was having her eye evaluated by an unspecified physician. At the time of reporting, the outcome of the event was unknown. This is one of several reports from the same reporter. Additional information has been requested.
Discharge Provider: DO Primary Care Provider: DO Admission Date: 9/23/2022 Discharge Date: 10/3/2022   PRESENTING PROBLEM: Pleural effusion  Hypoxia  Acute respiratory failure with hypoxia (HCC)  Hypotension, unspecified hypotension type  Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type COVID-19    HOSPITAL COURSE:   Patient is a 76 y.o. male with PMH of coronary artery disease, chronic AFib, COPD, chronic systolic heart failure, ischemic cardiomyopathy, CABG. recurrent right pleural effusions who presented on 9/23 with shortness of breath. A few days before admission he noticed that with exertion he was more winded than usual. He thought he had allergies because he had rhinorrhea, coughing, increased sputum, congestion with no fevers. He usually wears 2L at night, but started needing oxygen during the day as well. COVID test was positive. During admission, he was treated for acute hypoxic respiratory failure secondary to COVID, COPD exacerbation, right pleural effusion, and acute on chronic heart failure. His symptoms dramatically improved with IV diuresis, decadron, remdesivir. Thoracentesis with performed, showing exudative fluid.  Additionally, the patient was seen by the wound care team regarding lower extremity wounds. ABI was abnormal. Vascular saw the patient and recommended compression stockings with outpatient follow up.    Pt diuresed well throughout his hospital stay, with his oxygen needs returning to baseline. The pt has a new estimated dry weight of 97.5 kg. The pt was previously on Warfarin for a-fib. Consideration was given to transitioning to Eliquis, for which the patient was agreeable. After discussion with pulmonology, who is planning to perform a thoracoscopy on 10/5, the pt was instructed to start this after the procedure. Will hold all anticoagulation per pulmonary recommendations (no warfarin, Eliquis, or ASA) until post procedure. The pt's torsemide was decreased from 20mg BID to 20mg once daily as he continued to have diuresis on day of discharge. His potassium was decreased to once daily. His home losartan was also decreased to 12.5 mg daily, and was continued for the cardioprotective remodeling benefits.    Pt discharged to SAR on 10/3 in stable condition.
I got some vertigo. I noticed it before I went to bed. It was still there in the morning. I went to the ER and they put me on Meclizine. They did an MRI or CAT scan of my head, EKG, and they could not determine if there was something going on in my ears. When it did not clear out I followed up with my regular doctor and then the ENT. The ENT put me on Prednisone. The doctor did another test and a standard hearing test. They said I have vertigo. I saw the ENT a couple of weeks before this and he said I had some pressure in my ears.
Got a sudden heart attack after developing chest pain/discomfort while walking  outside on 3/20 afternoon time. Went to ER and shifted to hospital. Treated with 2 stents in heart. Arteries were found blocked and blood clot was removed.
Left deltoid swelling, redness, and itchy 5 days after tetanus given.  Took Benadryl which helped.  Signs and symptoms began 3 days after injections.
Red dots under skin/ some of them bleed/ bleeding under my skin; Skin lesions on her arms and chest, torso; some become purple, reddish-purple, red-blue; One of them looks like a blister; Felt achey; The flu and all that; Felt crappy; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (The flu and all that), FEELING ABNORMAL (Felt crappy), RASH MACULAR (Red dots under skin/ some of them bleed/ bleeding under my skin), SKIN LESION (Skin lesions on her arms and chest, torso) and SKIN DISCOLOURATION (some become purple, reddish-purple, red-blue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included NORTRIPTYLINE for an unknown indication.    On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced INFLUENZA (The flu and all that), FEELING ABNORMAL (Felt crappy) and MYALGIA (Felt achey). On an unknown date, the patient experienced RASH MACULAR (Red dots under skin/ some of them bleed/ bleeding under my skin), SKIN LESION (Skin lesions on her arms and chest, torso), SKIN DISCOLOURATION (some become purple, reddish-purple, red-blue) and BLISTER (One of them looks like a blister). At the time of the report, INFLUENZA (The flu and all that), FEELING ABNORMAL (Felt crappy), RASH MACULAR (Red dots under skin/ some of them bleed/ bleeding under my skin), SKIN DISCOLOURATION (some become purple, reddish-purple, red-blue), BLISTER (One of them looks like a blister) and MYALGIA (Felt achey) outcome was unknown and SKIN LESION (Skin lesions on her arms and chest, torso) had not resolved.            Treatment medication was not provided.   This case was linked to MOD-2021-228419 (Patient Link).
excessive screaming, breath holding, limpness & blue/purple color responded to stimuli; swollen leg @ DTP site;
Patient noticed her face starting to swell up when she drove home from the vaccination appointment. Her forehead swelled up and she noticed white lumps caused by the swelling. She called "ask a nurse" and they told her to take benadryl. This did help relieve the pressure and she did not need to seek additional treatment.
Vomiting; had spot on her arm near the injection site that was round, red, hard and hot to touch; had spot on her arm near the injection site that was round, red, hard and hot to touch; had spot on her arm near the injection site that was round, red, hard and hot to touch; had spot on her arm near the injection site that was round, red, hard and hot to touch; Slight Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (had spot on her arm near the injection site that was round, red, hard and hot to touch), VACCINATION SITE RASH (had spot on her arm near the injection site that was round, red, hard and hot to touch), VACCINATION SITE INDURATION (had spot on her arm near the injection site that was round, red, hard and hot to touch), VACCINATION SITE ERYTHEMA (had spot on her arm near the injection site that was round, red, hard and hot to touch) and HEADACHE (Slight Headache) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE WARMTH (had spot on her arm near the injection site that was round, red, hard and hot to touch), VACCINATION SITE RASH (had spot on her arm near the injection site that was round, red, hard and hot to touch), VACCINATION SITE INDURATION (had spot on her arm near the injection site that was round, red, hard and hot to touch), VACCINATION SITE ERYTHEMA (had spot on her arm near the injection site that was round, red, hard and hot to touch) and HEADACHE (Slight Headache). On 09-Feb-2021, the patient experienced VOMITING (Vomiting). On 08-Feb-2021, HEADACHE (Slight Headache) had resolved. On 09-Feb-2021, VOMITING (Vomiting) had resolved. At the time of the report, VACCINATION SITE WARMTH (had spot on her arm near the injection site that was round, red, hard and hot to touch), VACCINATION SITE RASH (had spot on her arm near the injection site that was round, red, hard and hot to touch), VACCINATION SITE INDURATION (had spot on her arm near the injection site that was round, red, hard and hot to touch) and VACCINATION SITE ERYTHEMA (had spot on her arm near the injection site that was round, red, hard and hot to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information not provided
improperly stored vaccines; No adverse event; This spontaneous report was received from a registered nurse, referring a patient of unknwon age and gender. The patients' pertinent medical history, current conditions, previous drug reactions or allergies were not reported.  On an unknown date the patient was vaccinated with an was administered improperly stored doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # T007035 with expiration date on 15-APR-2021 and T007035, 01-MAY-2022 , hepatitis a vaccine, inactivated (VAQTA): T014590, expiration: 15-APR-2021, T014589, expiration: 25-OCT-2021, Hepatitis A Vaccine, Inactivated (VAQTA), Hepatitis B Vaccine (Recombinant)(RECOMBIVAX HB): T025374, expiration 25-JAN-2023, and a dose of  Pneumococcal Vaccine, Polyvalent (23-valent)(PNEUMOVAX23) (formulation, strength, dose, vaccination scheme, route of administration and anatomical site of vaccination were not reported), However no adverse events were reported.   t was reported that the vaccines were exposed to temperature of 15.8 Centigrade range for a time frame of 22 minutes The temperature excursion was recorded by a data logger and no previous excursions were reported for the vaccines. There was no product quality complaint involved.  Lot Number T017285 is an invalid to number for Pneumococcal Vaccine, Polyvalent (23-valent)(PNEUMOVAX23).
11/15 (day after imz) some redness beginning 11/16 pt reported swelling continues and becomes firm to touch and seeks medical attention. MD rx antibiotics and steroids for cellulitis-type reaction.
This is a spontaneous report from a contactable nurse. A 72-year-old female patient received PREVNAR 13 (lot# M27559, exp date Apr2017, NDC 0005197101), intramuscular, on 20Jan2016, at 0.5 single. Relevant medical history included blood pressure abnormal and hypothyroidism. Concomitant medications included hydrochlorothiazide (unspecified trade name), from an unspecified date and ongoing, at 25 mg 1x/day, for blood pressure; levothyroxine (unspecified trade name), from an unspecified date and ongoing, at 100 ug daily, for hypothyroidism and quinapril (unspecified trade name), from an unspecified date and ongoing, at 40 mg 1x/day, for blood pressure. The patient experienced arm soreness on 20Jan2016 with outcome of recovered and 3-4 days after sore throat with outcome of unknown and swollen glands with outcome of not recovered. On 30Jan2016 muscle pain with outcome of not recovered, difficult for her to get out of bed with outcome of unknown; she had joint pain which persisted in her neck and shoulders, lower back, knees, groin, hips buttocks, basically on her whole body with outcome of not recovered; all over body ache with outcome of unknown. The nurse mentioned that the patient believed that all the side effects were related to PREVNAR 13 but the nurse had no idea about it, as the patient had never complained about these problems before. Follow-up (20APR2016): Follow-up attempts completed. No further information expected.